Injected Heroin Use Still High in U.S., May Explain HCV Infection Rate Injected Heroin Use Still High in U.S., May Explain HCV Infection Rate

Heroin use by injection has leveled off in recent years but had been rising steadily for more than a decade, a study finds.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Psychiatry News Source Type: news

Related Links:

This article aims to describe initiatives that have been implemented that promote physical activity. More family physicians have become interested in promoting physical activity in their clinical practice. Specific training has become more widely available, computer based tools have been developed as clinical practice aids (for evaluation of levels of physical activity and counselling) and local initiatives involving health professionals have increased, as well as more investment in terms of investigation and monitoring of all of the above. At the same time change is happening among urban spaces and local policies that fav...
Source: Ciencia e Saude Coletiva - Category: Occupational Health Source Type: research
Conclusion: Patients with HIV infections with quantitative CMV-DNA levels>6,390 copies/mL have a higher probability of having a diagnosis of CMV retinitis and a worse prognosis than those whose CMV-DNA level is
Source: Frontiers in cellular and infection microbiology - Category: Microbiology Source Type: research
Photo credit William Krause Dear Carol: My 93-year-old grandma has hearing aids, but she refuses to wear them. Her hearing without them is poor, and while she's taught herself to read lips, that only works if I'm standing right in front of her. My husband's so frustrated that he stood in front of her the other morning and said, “I am not going to talk to you until you put your hearing aids in your ears.” I understand his frustration, but his response doesn't seem right either. Could there be some logical reason why Grandma won't wear her hearing aids? — WS. Continue reading on Inforum to learn more a...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
lin Acquired Immune Deficiency Syndrome (AIDS) treatment with combination antiretroviral therapy (cART) has improved the life quality of many patients since its implementation. However, resistance mutations and the accumulation of severe side effects associated with cART remain enormous challenges that need to be addressed with the continual design and redesign of anti-HIV drugs. In this review, we focus on the importance of the HIV-1 Gag polyprotein as the master coordinator of HIV-1 assembly and maturation and as an emerging drug target. Due to its multiple roles in the HIV-1 life cycle, the individual Gag domains ar...
Source: Molecules - Category: Chemistry Authors: Tags: Review Source Type: research
Perinatal antiretroviral intensification may prevent intrapartum transmission of HIV in women who start combination antiretroviral therapy (cART) late in pregnancy, new research suggests.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Funding to enhance nursing education and strengthen the nursing workforce through experiential learning opportunities, including the use of simulation-based technology to improve the health of patients, families, and communities in rural and medically underserved areas experiencing diseases and conditions that affect public health. Geographic coverage: Nationwide -- Health Resources and Services Administration, U.S. Department of Health and Human Services
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - Category: Infectious Diseases Source Type: funding
Purpose of review The available vaccine and therapies against hepatitis B virus (HBV) rarely eliminate chronic infection with the virus. High mortality resulting from complicating cirrhosis and hepatocellular carcinoma makes improving anti-HBV therapy an important priority. Recent advances with using gene therapy to counter HBV have potential and are the focus of this review. Recent findings The stable replication-competent HBV intermediate comprising covalently closed circular DNA (cccDNA) is the template for expression of all viral genes. Inactivating cccDNA has thus been a focus of research aimed at achieving cure ...
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
Purpose of review The cure for hepatitis C virus infection has raised hope for a potential hepatitis B virus (HBV) cure, but the high price tag has led to serious questions about the affordability, and thus to access for all. This review discusses cost-effectiveness models, affordability, and access to a potential new cure for chronic HBV infection. Recent findings A cure does not yet exist for HBV, but the antiviral treatments that are currently available help slow down the progression of disease. There is limited research in the area of cost-effectiveness and economic analysis comparing a potential cure. Our prelimi...
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
No abstract available
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: EDITORIAL INTRODUCTIONS Source Type: research
No abstract available
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
More News: HIV AIDS | Infectious Diseases | Psychiatry | Study